Coronavirus Inhaler | US Coronavirus Updates, COVID-19 News; Scientists Latest Research On Nasal Sprays (Inhaler) | US scientists claim – Anti-corona nasal spray with nanobodies will not allow the virus to move through the nose, it is more effective than PPE.

American scientists have created an inhaler that will give more protection than PPE to prevent corona. Researchers at the University of California have made this claim in their research. This inhaler is named Aeronabs, which must be sprayed into the nose to be used. This inhaler contains special nanobodies, which are prepared with antibodies. These antibodies are found in animals such as lamas and camels, which give strong immunity to the body. But nanobodies present in the inhaler have been prepared in the lab. These are genetically modified, specifically developed to block the corona.

What are nanobodies
Antibodies work in the corona to prevent infection from spreading during the experiment. Nanobodies, like antibodies, are made up of proteins. These are short forms of antibodies and can be produced in greater numbers. Nanobodies were discovered in 1980 in a lab in Belgium.

Nanobodies prevent such corona
According to the researchers, when the corona attaches to a human's ACE2 receptor with its spike protein to spread infection, these nanobodies block its protein. When this occurs, the virus cannot bind to the ACE2 receptor and is not infected. The ACE2 receptor is found on the surface of human cells, which is the entry point for infection with the corona.

Corona was neutralized by nanobodies at the time of the SARS epidemic.
According to researcher Peter Wolter, Aronabs may be a permanent option to protect against the virus until a vaccine is made or available. Nanobodies were also designed to neutralize coronaviruses even during the SARS epidemic. According to researcher Dr. Ashish Manglik, the researchers created 21 such nanobodies in the lab that work against the corona.

Human trials will start soon
Researchers are in agreement with the manufacturing firm to make this nasal spray accessible. Hopefully, its human trial will start soon. If it meets 100 percent expectations then it can become a very easy and convenient solution to stop this epidemic.

0